The ACR’s 2018 Legislative & Regulatory Priorities
The Battle with Insurance Companies to Obtain Prescriptions
FDA’s Gottlieb Blames Industry ‘Kabuki Drug Pricing’ for High Costs
Patients Have No More Skin to Give: Dr. William Harvey Testifies on Rheumatology Issues before Senate Committee
